STRATTEC SECURITY CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data STRATTEC SECURITY CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	417	439	487	385	485	452	493	538	565	579
Cost of revenue	356	385	429	350	407	396	451	472	480	484
Gross profit	61	54.4	57.8	35.4	78.7	56	42.2	65.5	84.6	95.4
Research and development	4.6	4.8	13.8	9.8	10.8	12.2	15.9	14.8	21.7	21.8
Operating expenses	46.1	41.2	47.2	44.1	44.7	47.1	48.2	47.7	61.8	68.8
Operating income	14.8	13.3	10.6	-8.66	33.9	8.9	-6.09	17.8	22.8	26.5
Interest expense	0.42	1.14	1.62	0.92	0.3	0.22	0.96	0.9	1.01	0.36
Interest income	0.14	0.01						0.57	2.04	3.5
Other non-operating income	1.17	1.02	-0.34	1.67	-1.17	0.41	-2.18	2.72	0.82	3.3
Pre-tax income	16.4	17.7	-20.4	-8.12	35	9.26	-7.67	20.2	24.6	33
Income tax	4.28	2.07	-7.74	-2.27	5.11	0.42	1.28	3.78	5.72	11.3
Net income to minority interests	4.91	3.35	4.34	1.75	7.37	1.83	-2.28	0.12	0.23	1.03
Net income	7.2	12.3	-17	-7.61	22.5	7.02	-6.67	16.3	18.7	20.6
EBITDA	26.3	27.9	27.8	10.7	53.7	28.3	11.4	34.4	37.5	41.6
EPS, basic	2.01	3.39	-4.63	-2.04	5.95	1.82	-1.70	4.10	4.64	5.07
EPS, diluted	1.96	3.32	-4.63	-2.04	5.85	1.79	-1.70	4.07	4.58	5.00
Shares, basic (weighted)	3.59	3.63	3.68	3.74	3.79	3.86	3.92	3.98	4.03	4.06
Shares, diluted (weighted)	3.67	3.7	3.68	3.74	3.85	3.91	3.92	4	4.08	4.12
Dividend per share	0.56	0.56	0.56	0.42

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	8.36	8.09	7.81	11.8	14.5	8.77	20.6	25.4	84.6	108
Receivables	64.9	73.8	84.2	42	69.9	75.8	89.8	99.3	102	99.1
Inventory	35.5	46.7	47.3	54.4	70.9	80.5	77.6	81.6	64.7	64.3
Other current assets	6.7	6.45	6.98	5.56	6.39	5.31	6.38	5.28	8.21	5.81
Total current assets	129	151	157	125	175	188	226	254	290	296
Property, plant and equipment	112	117	118	105	96.4	91.7	94.4	86.2	77.4	69.8
Lease right-of-use assets				3.75	3.4	3.02	4.47	3.8	2.94	2.17
Intangible assets	0.04
Other non-current assets	16	17.3	11.5	6.47	6.98	5.44	7.08	6.7	4.45	5.28
Total assets	274	307	313	266	311	319	341	364	391	387
Accounts payable	39.7	38.4	41.9	18.5	36.7	44	57.9	54.9	65.8	55
Accrued liabilities	13.1	13.4	17.3	13.5	22.5	18	51.1	29	23	20.8
Total current liabilities	67.9	68.8	79.3	48.1	77.6	81.5	109	118	119	102
Lease liabilities				3.4	3.02	2.62	4	3.39	2.48	1.57
Other non-current liabilities	0.61	0.8	1.23	5.01	4.63	4.07	5.56	4.96	4.35	6.4
Total liabilities	101	124	125	90.1	97.8	99.2	130	139	145	122
Paid-in capital	93.8	95.1	96.5	98	99.5	102	100	101	104	107
Retained earnings	226	236	221	212	234	241	234	251	269	290
Treasury stock	-136	-136	-136	-136	-136	-136	-136	-135	-135	-144
Other comprehensive income	-32.9	-33.4	-18.6	-22.1	-16.9	-18.6	-14.2	-15.7	-16.1	-14.1
Shareholders' equity	151	162	163	152	181	188	185	201	222	239
Minority interests	21.6	21.1	24.4	23.2	31.8	31.5	26.1	25.1	24.8	26.9
Total equity	173	183	188	175	213	220	211	226	246	265
Total liabilities and equity	274	307	313	266	311	319	341	364	391	387
Shares outstanding	3.6	3.64	3.69	3.75	3.81	3.88	3.93	3.99	4.04	3.98

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	12.1	15.6	-12.7	-5.86	29.9	8.84	-8.95	16.4	18.9	21.6
Depreciation and amortization	11.4	14.6	17.2	19.3	19.8	19.4	17.5	16.5	14.8	15.1
Stock-based compensation	1.51	1.13	1.13	1	0.97	1.14	1.47	1.47	2.73	3.31
Deferred income tax	1.85	1.03	-10.1	-3.59	1.47	-1.99	-4.94	-4.71	-1.89	3.56
Change in receivables	-1.71	-9.57	-10.4	42	-27.7	-5.94	-13.7	-9.36	-3.09	2.99
Change in inventory	3.21	-11.2	-0.61	-7.14	-16.5	-9.62	2.89	-4.05	16.9	0.39
Change in payables	5.17	3.75	6.14	-24.2	28.5	1.81	24	-3.02	10.7	-10.4
Cash from operations	23.1	6.94	29.9	25.4	35.2	10.4	10.1	12.3	71.7	46.3
Capital expenditures	-37	-24.1	-17.5	-12.4	-8.93	-14.2	-17.4	-9.79	-7.16	-7.33
Cash from investing	-39.5	-23.9	-17.6	-12.3	-9.02	-14.3	8.9	-7.79	-7.16	-5.4
Stock issued	0.14	0.14	0.17	0.48	0.53	0.83	0.11
Share buybacks								0	0	-7.4
Dividends paid	-2.01	-2.03	-2.06	-1.57
Cash from financing	9.23	16.4	-12.2	-8.99	-22.9	-1.89	-7.44	0.07	-4.94	-16.9
Net change in cash	-7.12	-0.27	-0.28	3.97	2.69	-5.69	11.8	4.84	59.2	23.7
Free cash flow	-13.9	-17.2	12.5	13	26.2	-3.75	-7.28	2.48	64.5	39
Interest paid	0.35	1.08	1.62	0.98	0.32	0.23	0.89	0.89	1.01	0.22
Income taxes paid	0.32	2.5	0.53	2.11	5.43	-0.84	2.76	3.8	14.2	4.75

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 27, 2026; growth uses fiscal years. Valuation uses the share price of $61.02 on November 10, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	16.3%	Gross profit / revenue.
Operating margin	3.9%	Operating income / revenue.
EBITDA margin	6.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.1%	Pre-tax income / revenue.
Net margin	2.9%	Net income / revenue.
FCF margin	6.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.0%	Cash from operations / revenue.
Effective tax rate	37.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	7.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.4%	Net income / average total assets.
Return on invested capital (ROIC)	11.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.2%	Capital expenditures / revenue.
D&A / revenue	2.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	2.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	12.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	31.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	16.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y	-4.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	10.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	54.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-5.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	10.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	-1.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	9.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	-3.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-35.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	66.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	5.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-39.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	8.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	5.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	4.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.02x	Current assets / current liabilities.
Quick ratio	2.13x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.15x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	30.5%	Total liabilities / total assets.
Interest coverage	93.7x	Operating income / interest expense.
Working capital	$196.0M	Current assets - current liabilities.
Tangible book value	$237.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.50x	Revenue / average total assets.
Fixed asset turnover	8.53x	Revenue / average property, plant and equipment.
Inventory turnover	7.41x	Cost of revenue / average inventory.
Days inventory	49 days	365 x average inventory / cost of revenue.
Receivables turnover	6.04x	Revenue / average receivables.
Days sales outstanding	60 days	365 x average receivables / revenue.
Days payables	42 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	68 days	Days inventory + days sales outstanding - days payables.
FCF conversion	229.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	15.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$4.17	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$141.67	Revenue / diluted weighted shares.
FCF per share	$9.56	Free cash flow / diluted weighted shares.
Operating cash flow per share	$11.29	Cash from operations / diluted weighted shares.
Book value per share	$58.69	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$58.69	Tangible book value / shares outstanding.
Cash per share	$27.58	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$255.0M	Share price x shares outstanding.
Enterprise value	$143.2M	Market cap + total debt - cash - short-term investments.
P/E	15.1x	Market cap / net income. Only when net income is positive.
P/S	0.44x	Market cap / revenue.
P/B	1.07x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.07x	Market cap / tangible book value, when positive.
P/FCF	6.58x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.57x	Market cap / cash from operations, when positive.
EV/Sales	0.25x	Enterprise value / revenue.
EV/EBIT	6.37x	Enterprise value / operating income, when both are positive.
EV/EBITDA	3.84x	Enterprise value / EBITDA, when both are positive.
EV/FCF	3.70x	Enterprise value / free cash flow, when both are positive.
FCF yield	15.2%	Free cash flow / market cap.
Earnings yield	6.6%	Net income / market cap (the inverse of P/E).

What was STRATTEC SECURITY CORP's revenue in fiscal 2026?

STRATTEC SECURITY CORP reported revenue of $579.4M for fiscal 2026, 2.5% higher than the year before.

Was STRATTEC SECURITY CORP profitable in fiscal 2026?

Yes. Net income was $20.6M, a net margin of 3.6%.

How much free cash flow did STRATTEC SECURITY CORP generate in fiscal 2026?

Cash from operations of $46.3M minus capital expenditures of $7.3M left free cash flow of $39.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to STRATTEC SECURITY CORP